Exogenous Nav1.1 activity in excitatory and inhibitory neurons reverts Dravet syndrome comorbidities when delivered post-symptom onset in mice with Dravet
Saja Fadila, Bertrand Beucher, Iria G. Dopeso‐Reyes, Anat Mavashov, Marina Brusel, Karen Anderson, Ethan M. Goldberg, Ana Ricobaraza, Rubén Hernández-Alcoceba, Eric J. Kremer, Moran Rubinstein
This study shows that delivering a modified SCN1A gene via viral vectors to DS mice improves survival, reduces seizures, and corrects brain activity after symptom onset.
bioRxiv · Jun 10, 2022 · PreprintNeuroscience